29 related articles for article (PubMed ID: 29529220)
1. Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer.
Liu C; Eng C; Shen J; Lu Y; Takata Y; Mehdizadeh A; Chang GJ; Rodriguez-Bigas MA; Li Y; Chang P; Mao Y; Hassan MM; Wang F; Li D
Oncotarget; 2016 Nov; 7(46):76250-76260. PubMed ID: 27788488
[TBL] [Abstract][Full Text] [Related]
2. Serum MicroRNA profile in patients with colon adenomas or cancer.
Zhang Y; Li M; Ding Y; Fan Z; Zhang J; Zhang H; Jiang B; Zhu Y
BMC Med Genomics; 2017 Apr; 10(1):23. PubMed ID: 28427387
[TBL] [Abstract][Full Text] [Related]
3. Spatial tumour gene signature discriminates neoplastic from non-neoplastic compartments in colon cancer: unravelling predictive biomarkers for relapse.
Sallinger K; Gruber M; Müller CT; Bonstingl L; Pritz E; Pankratz K; Gerger A; Smolle MA; Aigelsreiter A; Surova O; Svedlund J; Nilsson M; Kroneis T; El-Heliebi A
J Transl Med; 2023 Aug; 21(1):528. PubMed ID: 37543577
[TBL] [Abstract][Full Text] [Related]
4. BK002 Induces miR-192-5p-Mediated Apoptosis in Castration-Resistant Prostate Cancer Cells
Park MN; Park H; Rahman MA; Kim JW; Park SS; Cho Y; Choi J; Son SR; Jang DS; Shim BS; Kim SH; Ko SG; Cheon C; Kim B
Front Oncol; 2022; 12():791365. PubMed ID: 35321434
[TBL] [Abstract][Full Text] [Related]
5. Hirschsprung's disease: key microRNAs and target genes.
Hong M; Li X; Li Y; Zhou Y; Li Y; Chi S; Cao G; Li S; Tang S
Pediatr Res; 2022 Sep; 92(3):737-747. PubMed ID: 34880446
[TBL] [Abstract][Full Text] [Related]
6. Expression of miR-192-5p in colon cancer serum and its relationship with clinicopathologic features.
Chen X; Su X; Lin M; Fu B; Zhou C; Ling C; Qian Z; Yao Y
Am J Transl Res; 2021; 13(8):9371-9376. PubMed ID: 34540055
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and Prognostic Role of miR-192 in Different Cancers: A Systematic Review and Meta-Analysis.
Wang L; Liu Y; Lyu C; Buchner A; Pohla H
Biomed Res Int; 2021; 2021():8851035. PubMed ID: 33614788
[TBL] [Abstract][Full Text] [Related]
8. A network view of microRNA and gene interactions in different pathological stages of colon cancer.
Wen J; Hall B; Shi X
BMC Med Genomics; 2019 Dec; 12(Suppl 7):158. PubMed ID: 31888617
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of microRNA-9 and -192 expression levels as biomarkers in patients suffering from breast cancer.
Tavakolian S; Goudarzi H; Torfi F; Faghihloo E
Biomed Rep; 2020 Jan; 12(1):30-34. PubMed ID: 31839947
[TBL] [Abstract][Full Text] [Related]
10. Study on miRNAs in Pan-Cancer of the Digestive Tract Based on the Illumina HiSeq System Data Sequencing.
Lai CH; Liang XZ; Liang XY; Ma SJ; Li JG; Shi MF; Zhu X; Lan HH; Zeng JH
Biomed Res Int; 2019; 2019():8016120. PubMed ID: 31737678
[TBL] [Abstract][Full Text] [Related]
11. Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma.
Lopez G; Boggio F; Ferrero S; Fusco N; Del Gobbo A
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30282914
[TBL] [Abstract][Full Text] [Related]
12. An Insight into the Difficulties in the Discovery of Specific Biomarkers of Limbal Stem Cells.
Guo ZH; Zhang W; Jia YYS; Liu QX; Li ZF; Lin JS
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986467
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients.
Li P; Ou Q; Braciak TA; Chen G; Oduncu FS
Jpn J Clin Oncol; 2018 Jul; 48(7):619-624. PubMed ID: 29529220
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
15. Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer.
Lee IH; Kim G; Kwak SG; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Hur K; Kim JG
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513887
[TBL] [Abstract][Full Text] [Related]
16. Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer.
Weissmann-Brenner A; Kushnir M; Lithwick Yanai G; Aharonov R; Gibori H; Purim O; Kundel Y; Morgenstern S; Halperin M; Niv Y; Brenner B
Int J Oncol; 2012 Jun; 40(6):2097-103. PubMed ID: 22426940
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite Instability as a Prognostic Factor in Stage II Colon Cancer Patients, a Meta-Analysis of Published Literature.
Gkekas I; Novotny J; Pecen L; Strigård K; Palmqvist R; Gunnarsson U
Anticancer Res; 2017 Dec; 37(12):6563-6574. PubMed ID: 29187431
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
